Predict your next investment

Corporation
HEALTHCARE | Drug Development
ptcbio.com

See what CB Insights has to offer

Founded Year

1998

Stage

IPO | IPO

Total Raised

$292.3M

Date of IPO

6/20/2013

Market Cap

3.09B

Stock Price

42.59

Revenue

$0000 

About PTC Therapeutics

PTC Therapeutics (NASDAQ: PTCT) is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC has assembled technologies and extensive knowledge of post-transcriptional control processes that it applies in its drug discovery and development activities. PTC's pipeline of clinical and preclinical product candidates addresses multiple indications, including genetic disorders, oncology, and infectious diseases.

PTC Therapeutics Headquarter Location

100 Corporate Court

South Plainfield, New Jersey, 07080,

United States

908-222-7000

Latest PTC Therapeutics News

PTC Therapeutics Announces Launch of 2022 Global Talent Pipeline Program

Jan 13, 2022

01/13/2022 | 08:01am EST Message : *Required fields SOUTH PLAINFIELD, N.J., Jan. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of the company's 2022 Talent Pipeline Program, a one-year, global initiative designed to provide recent college graduates with high-quality, real-world opportunities at work. Throughout this immersive program, participants receive benefits such as mentorship, job coaching, career counseling and leadership development training. "We are proud that the Talent Pipeline Program has provided such rewarding experiences to both the Fellows of the Talent Pipeline Program as well as our PTC employees," said Stuart W. Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics. "Because of its success, we are thrilled to continue this innovative program for a second year. We are excited to bring in a new group of young, talented people and have them join the PTC family and to provide them with a rich opportunity to utilize their education to learn and grow." Fellow selection process, manager support and on-the-job activities are aligned with PTC's goal to attract, develop and retain the best and brightest talent. The 2022 application period will begin on Feb. 11, 2022, and the program will commence in June 2022. About the Talent Pipeline Program The 2022 Talent Pipeline Program will include approximately 30 Fellows for a one-year program of work experience with a stipend. Some positions will require that participants to live near PTC's research or manufacturing sites in New Jersey and California, and other positions will be remote. Successful Fellows will receive a Certificate of Completion, a letter of reference and consideration for future positions at PTC. For more information on the Talent Pipeline Program, please visit https://www.ptcbio.com/careers/talent-pipeline-program-fellowship/ . About PTC Therapeutics, Inc. PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn. For More Information:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PTC Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PTC Therapeutics is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

818 items

PTC Therapeutics Patents

PTC Therapeutics has filed 182 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Neurological disorders
  • Syndromes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/17/2020

11/30/2021

Alkanes, Amines, Acetylcholinesterase inhibitors, Chemical processes, Commodity chemicals

Grant

Application Date

8/17/2020

Grant Date

11/30/2021

Title

Related Topics

Alkanes, Amines, Acetylcholinesterase inhibitors, Chemical processes, Commodity chemicals

Status

Grant

PTC Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PTC Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.